ZyVersa Therapeutics Inc (ZVSA) concluded trading on Wednesday at a closing price of $0.71, with 13.26 million shares of worth about $9.41 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -42.74% during that period and on June 25, 2025 the price saw a gain of about 7.58%. Currently the company’s common shares owned by public are about 4.77M shares, out of which, 4.76M shares are available for trading.
Stock saw a price change of 10.94% in past 5 days and over the past one month there was a price change of 31.48%. Year-to-date (YTD), ZVSA shares are showing a performance of -82.34% which decreased to -33.02% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.47 but also hit the highest price of $6.30 during that period. The average intraday trading volume for ZyVersa Therapeutics Inc shares is 3.72 million. The stock is currently trading 8.32% above its 20-day simple moving average (SMA20), while that difference is up 12.22% for SMA50 and it goes to -42.59% lower than SMA200.
ZyVersa Therapeutics Inc (NASDAQ: ZVSA) currently have 4.77M outstanding shares and institutions hold larger chunk of about 7.44% of that.
The stock has a current market capitalization of $3.39M and its 3Y-monthly beta is at 0.78. It has posted earnings per share of -$7.78 in the same period. It has Quick Ratio of 0.18 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ZVSA, volatility over the week remained 6.85% while standing at 6.11% over the month.
Analysts are in expectations that ZyVersa Therapeutics Inc (ZVSA) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same.
